Marijuana Use Tied to Worse School Outcomes for Teens
By Ernie Mundell HealthDay Reporter
MONDAY, Oct. 7, 2024 -- Generations of parental warnings may not be wrong: A massive study of available data finds teens who use marijuana have significantly worse outcomes at school.
Data from 63 studies involving almost 440,000 youths found "cannabis use during adolescence is probably associated with lower school grades; less likelihood of high school completion, university enrollment and post-secondary degree attainment; and increased school dropout rate and school absenteeism," according to Canadian researchers.
The study was led by Li Wang, of McMaster University in Hamilton, Ontario, and published Oct. 7 in the journal JAMA Pediatrics.
As the research team noted, one 2019 study found more than one in every five (22%) U.S. high school students reporting marijuana use at least once over the past month. Weed is also much more potent now than in decades past, with THC levels rising from 4% in 1995 to 14% by 2019.
"Chronic use among adolescents has been linked to long-term changes in brain architecture," the study authors say, "resulting in impaired information processing and decreased cognitive, memory and attentive capacity in adulthood."
So what effect might these impairments have on academics?
To find out, Wang's team collected data from dozens of studies looking at marijuana use and academics and employment among youth.
Some of the data was more reliable than others, but the researchers found "moderate-certainty" evidence that cannabis use in adolescence and young adulthood was linked to a:
39% higher odds for lower school grades
50% less chance of attaining a high school diploma
28% lower likelihood of going to university
31% lower odds for getting a college degree
more than doubling of the odds of dropping out of high school
more than doubling of the odds of school absenteeism
There was also "low-certainty" evidence that cannabis use in youth was tied to unemployment, Wang's group found.
All of these risks rose with the frequency of marijuana use, and if use began early (at or before the age of 16), the analysis also found.
They stressed that the data cannot fully prove that marijuana use causes all these deleterious outcomes.
For example, young people with mental health issues or other substance-use disorders may be predisposed to both use cannabis and perform less well at school, the team reasoned.
Still, they say their results were "adjusted for other substance use or mental disorders."
What's certain is that as the United States and other countries decriminalize marijuana use, and public acceptance grows, uptake by youth is surging.
"U.S. national estimates indicate that more than 3 million youth aged 12 to 17 years have used cannabis in the past year, which is greater use than any other illicit drug," Wang and colleagues said.
They believe that, given the results of their study and these surging numbers, "Effective interventions to prevent early cannabis exposure are urgently needed."
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-08 06:00
Read more
- Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue
- Recreational Cannabis Legalization Tied to Higher Prenatal Use
- Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia
- FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Global Coverage With Measles Vaccine Declined During COVID-19
- Vitamin D Supplements Could Help Lower Blood Pressure in Obese People
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions